Chardan Capital Cuts Cognition Therapeutics (NASDAQ:CGTX) Price Target to $4.00
Cognition Therapeutics (NASDAQ:CGTX – Free Report) had its price target lowered by Chardan Capital from $8.00 to $4.00 in a report issued on Thursday morning,Benzinga reports. The firm currently has a buy rating on the stock. Other analysts have also recently issued research reports about the stock. HC Wainwright cut their target price on shares […]
Cognition Therapeutics (NASDAQ:CGTX – Free Report) had its price target lowered by Chardan Capital from $8.00 to $4.00 in a report issued on Thursday morning,Benzinga reports. The firm currently has a buy rating on the stock. Other analysts have also recently issued research reports about the stock. HC Wainwright cut their target price on shares […]
